ResMed breathes more easily
Article Abstract:
The shareprice of ResMed, whose home exchange is New York, and it trades on the Australian Stock Exchange as a Chess Depository Interest (CDI) took a down inclination after a very successful gap and has again moved back to the top, hence had to keep a close look on its margins. The market report regarding the share price of 2002-03 of New York and Australian stock exchange is given, and it attributes its reason for lower profit margin to currency movements.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Hearing test: executive defection, government investigation and a plunging share price are not the welcome Cochlear's new chief wanted
Article Abstract:
The investigation of its sales and marketing activities of the Australian medical-device company Cochlear, by the US Department of Justice is discussed. The effect of this on the company's share price is described.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
ResMed Inc
Article Abstract:
A comparative analysis of the sales earnings and the financial details of ResMed Inc. from the year 1995-2003 are detailed. Different financial ratios according to the Value Line Publication are given.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Sacrificial families. Crash and burn: more executives now know the risks of burnout and are refusing to be work machines any longer
- Abstracts: Goodbye gloom (sob). Healthy correction: recent falls on US stockmarkets are no cause for concern. Is this the recovery?
- Abstracts: A healthy correction. High and handsome: The stockmarket is soaring, but it now faces new tests
- Abstracts: The Value Line view. The Value Line view u economic and stock market commentary
- Abstracts: Reforms need further review. Cracks in the Chinese wall. A wrong way to the top